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Background: Conventional G-band karyotyping offers low-resolution detection of chromosome abnormalities and
cannot provide information about the involved genomic content. On the other hand, array comparative genomic
hybridization can offer a rapid and comprehensive detection of genomewide gains and losses with higher resolution,
thus providing the genetic basis for prenatal diagnosis of fetal abnormalities.
Case presentation: A 35-year-old primigravid underwent cordocentesis at 28 weeks gestation due to the presence of
polyhydramnios, intrauterine growth retardation, persistent right umbilical vein and mild stenosis of aortic arch at the
ultrasound scan. Conventional G-band chromosome analysis revealed an apparently normal karyotype whereas the
array CGH detected a de novo 8.97 Mb deletion at chromosome 11q22.3→ q23.3 and offered a precise characterization
of the genetic defect.
Conclusions: The array CGH detected a de novo interstitial 11q deletion with its precise location and size which could
be missed or confused by G-band chromosome analysis. The breakpoint was close to the folate sensitive rare fragile site
FRA11B and the aphidicolin inducible common fragile site FRA11G, the co-localization fragile site could have caused
instability and constitutional chromosomal breakage. This case study indicates that array CGH is a useful technique for
detecting small unbalanced chromosomal abnormalities and should be an integral part of prenatal diagnosis for fetal
malformations.
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The incidence of major structural birth defects in China
is approximately 5.6% [1] and is associated with inher-
ited or de novo genetic rearrangements and mutations
as well as with maternal risk factors, such as advanced
age, exposure to teratogenic factors, illnesses and infec-
tions. The detailed second trimester ultrasound scan can
detect major fetal malformations and is offered for rou-
tine prenatal care. The genetic basis of abnormal ultra-
sound findings is important for prenatal diagnosis and
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unless otherwise stated.Conventional Giemsa-band (G-band) karyotyping on
metaphase cells, which is the standard procedures used
for prenatal cytogenetic diagnosis for over 40 years, can
detect aneuploidy, unbalanced and apparently balanced
structural rearrangements, and deletions/duplications of
at least 5-10 Mb. The culturing process usually takes
several days to a few weeks in order to generate the
number of metaphase chromosomes enough for a full
karyotype report. Moreover, G-band karyotyping lacks
the resolution to assess the involved genomic content.
These limitations hinder the inference of karyotype–
phenotype predictions and the identification of candi-
date genes associated with fetal anomalies.
As in the majority of cases with ultrasound abnormalities
the karyotype in the fetus is normal, thus demonstratingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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higher diagnostic capacity [2]. Array comparative gen-
omic hybridization (array CGH) has been introduced in
prenatal diagnosis to rapidly detect genomewide gains
and losses with higher resolution [3]. It is a high
throughput method which can detect copy number
changes to a resolution of even as low as 1 Kb. Array
CGH is rapidly replacing conventional G-band karyo-
typing in postnatal diagnosis of children with develop-
mental, intellectual, and physical disabilities [4-7], but
its application in prenatal diagnosis is still limited. Sev-
eral groups have demonstrated that by applying array
CGH for prenatal diagnosis of fetal ultrasound abnor-
malities, there was an increased detection rate over
G-band karyotyping or other molecular cytogenetic
techniques [8-11].
In this paper, we demonstrate the application of array
CGH in prenatal diagnosis, which permits the rapid iden-
tification of a de novo interstitial deletion of 11q
(11q22.3→ q23.3) in a fetus with abnormal ultrasound
findings.
Case presentation
A 35-year-old primigravid was referred to our hospital at
18 weeks of gestation for genetic counseling. The par-
ents were healthy and nonconsanguineous. There was
no family history of congenital malformations or genetic
disorders. The mother was tested negative for toxo-
plasma, CMV, herpes, and rubella. No drugs or infections
were reported during the course of the pregnancy. After in-
formed about the possible risk of a chromosomal abnormal-
ity in the presence of advanced maternal age, the couple
decided to receive noninvasive chromosomal aneuploidy
screening. We performed sequencing analysis of the cell free
DNA extracted from the maternal peripheral blood, and the
result turned out to be negative for trisomy 13, 18 and 21.
At 28 weeks of gestation the couple consulted our hos-
pital again due to the presence of polyhydramnios, intra-
uterine growth retardation, persistent right umbilical vein
and mild stenosis of aortic arch at the ultrasound scan.
Interventional prenatal diagnosis was referred to the
couple. A cordocentesis was carried out for prenatal diag-
nosis. Chromosome analysis was performed on cultured
cord blood lymphocytes by Giemsa banding at approxi-
mately 350 band resolution. The cytogenetics revealed
an apparently normal karyotype 46,XX (Figure 1) with
the limited banding resolution. Array CGH using Agi-
lent’s 8 × 60 K commercial arrays (Agilent Technologies,
Santa Clara, CA, USA) was performed on DNA ex-
tracted from uncultured cord blood and a 8.97 Mb dele-
tion was detected at chromosome 11q22.3-11q23.3 or
arr 11q22.3q23.3(107,686,511-116,660,613)x1 (Figure 2).
The molecular karyotyping refer to the Human Genome
February 2009 (versions GRCh37, hg19) assembly. Thearray CGH analysis of the parental blood did not reveal
any deletion at chromosome 11q, no balanced chromo-
somal rearrangements or inversions were found by
G-band karyotyping.
After genetic counseling, termination of pregnancy
was performed at parent’s request at 30 weeks of gesta-
tion. A female fetus was delivered with no apparent
phenotypic abnormalities. Autopsy was rejected by the
parents.
Conclusion
The majority of chromosome 11 long arm deletions are
at the terminal region, which is associated with a clinic-
ally well-described phenotype, called Jacobsen syndrome.
Whereas the interstitial deletions of chromosome 11q
are rarely observed, it may being resulted from a direct
de novo deletion or familial inheritance [12-14]. To our
knowledge, only 33 cases with interstitial 11q deletion
have been reported in literature and previous reports of
such cases have been associated with a wide variability
of phenotypic findings. Most of these cases had not been
analyzed with a molecular method, thus the phenotype-
genotype correlation was not very clear.
Among the 33 cases previously described, only six were
characterized with a molecular definition (Table 1). Dani-
jela Krgovic reported a deletion of chromosome 11q22.3
in a 5-year-old girl with mild mental retardation, develop-
mental and speech delay, facial dysmorphism, ptosis,
hypertelorism, low-set dysplastic ears, prominent forehead
and hypoplastic corpus callosum [15]. Peining Li reported
a deletion of chromosome 11q14.1→ q23.2 involving the
FZD4 gene in a patient with growth retardation, facial
anomalies, exudative vitreoretinopathy (EVR), cleft palate,
and minor digital anomalies [16]. Daniela Melis reported a
deletion of chromosome 11q13.5→ q14.2 in a 5-year-old
boy with low frontal hairline, flat profile, round face, full
cheeks, periorbital fullness, hypertelorism, broad nasal
bridge, down-turned corners of the mouth and develop-
mental delay [17]. Rebecca L. Sparkes reported a mater-
nally inherited 11q14.3→ q22.3 deletion of a male fetus,
the ultrasound scan revealed choroid plexus cysts, echo-
genic intracardiac foci, mild polyhydramnios, a relatively
enlarged right atrium with abnormal cardiac axis, small
cerebellum and left talipes equinovarus. The 38-year-old
mother with a 17, 3 Mb deletion (from nt 89,492,818 to
nt 106,832,040) and a 0.9 Mb duplication (from nt
88,258,744 to nt 89,103,489) in 11q21→ q23 was of nor-
mal intellect and healthy only with a surgically repaired bi-
lateral club foot and high myopia [14]. Josephine Wincent
reported a deletion of chromosome 11q13.4→ q14.3 in a
boy with microcephaly, ptosis and developmental delay
[18]. Renata Nacinovich followed up a boy with
11q14.3→ q22.3 deletion from early infancy to adoles-
cence, the proband was born with hypotonia and minor
Figure 1 G-banded karyotype of the fetus indicated an apparently normal 46,XX.
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and cognitive development were at the lower limit during
childhood [19].
As we mentioned above, due to the heterogeneity in
size and position of the deletions, it is not easy to define
a distinctive genotype/phenotype of the interstitial 11q
deletion. Most of the patients with an overlapping dele-
tion of this region had mild to severe mental retardation
and developmental delay, usually depending on the size
and position of the deletion. However, because our case
was diagnosed in uterus, it was not possible to investi-
gate the mental and developmental delay. In the only
prenatal diagnosed report, mild polyhydramnios and a
suspected structural cardiac malformation was described
[14], our case also shows the similar ultrasound results.
In the deleted region of this case, about 30 genes with
already known or unknown functions are mapped
[http://www.ncbi.nlm.nih.gov/]. In a proportion of pa-
tients with Jacobsen syndrome (terminal 11q deletions)
the breakpoints cluster in chromosomal subband
11q23.3 [20-22], a breakage-prone region which encom-
passes both the folate sensitive rare fragile site FRA11B
and the aphidicolin inducible common fragile site
FRA11G [20,23-25]. In our case, the deleted region maps
at 11q22.3→ q23.3, the breakpoint is on the proximal
side of FRA11G and FRA11B, indicating that the co-
localization fragile site could have caused instability and
constitutional chromosomal rearrangements in vivo
[23,26]. Aphidicolin inducible common fragile sites donot break at defined sequences but in breakage-prone
regions up to 10 Mb where the break is most likely to
appear [25,27,28]. The molecular basis of common fra-
gile site fragility has not been fully clarified. Common
fragile sites contain more areas of high DNA torsional
flexibility with more highly AT-dinucleotide-rich islands
than neighbouring non-fragile regions. The inconsist-
ency in DNA replication progression between fragile and
flanking non-fragile regions might contribute to occur-
rence of breaks at these fragile sites.
Folate sensitive fragile sites are caused by expansive mu-
tations of the normally occurring CCG/CGG trinucleotide
repeat sequences adjacent to a CpG island [29,30]. In ma-
jority of normal individuals this CCG/CGG repeat is
present in 8-80 copies [23]. The repeat can expand to 85–
100 copies as a premutation, without cytogenetic expres-
sion of the fragile site. During the premutation phase, the
repeats become highly unstable when transmitted to the
next generation. The offspring may then have a longer or
a shorter extension of the repeat sequence than the parent
[31]. In individuals with cytogenetic expression of the
FRA11B the repeat is expanded to several hundred copies.
This expansion is unstable and dependent upon the length
of the repeat tract: the longer the tract, the higher the in-
stability and probability of further expansion. It is hypoth-
esized that hypermethylation of the expanded CCG/CGG
trinucleotide on chromosome 11 could delay DNA repli-
cation of this fragile site, resulting in a break and/or im-
paired DNA replication [32].
Figure 2 Array CGH analysis of the fetus revealed a 8.97 Mb deletion at chromosome 11q22.3-11q23.3 or arr 11q22.3q23.3
(107,686,511-116,660,613)x1 (hg19; NCBI build 37).
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Table 1 Clinical manifestations related to interstitial 11q deletions (molecularly defined cases)
Segment deleted Clinical manifestations
11q22.3 mild mental retardation, developmental and speech delay, facial dysmorphism, ptosis, hypertelorism, low-set dysplastic ears,
prominent forehead, hypoplastic corpus callosum
11q14.1→ q23.2 growth retardation, facial anomalies, exudative vitreoretinopathy (EVR), cleft palate, minor digital anomalies
11q13.5→ q14.2 low frontal hairline, flat profile, round face, full cheeks, periorbital fullness, hypertelorism, broad nasal bridge, down-turned corners
of the mouth, developmental delay
11q14.3→ q22.3 choroid plexus cysts, echogenic intracardiac foci, mild polyhydramnios, a relatively enlarged right atrium with abnormal cardiac
axis, small cerebellum, left talipes equinovarus (Prenatal ultrasound result)
11q13.4→ q14.3 microcephaly, ptosis, developmental delay
11q14.3→ q22.3 mild developmental delay, submucous cleft palate
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tiple tumor associated rearrangements. On the distal side
of FRA11B lies the MLL gene. The MLL gene regulates
the HOX gene expression by directly binding to the pro-
moter sequences. Translocations involving the MLL gene
have been found in acute myeloid leukemia (AML), acute
lymphoblastic leukemia, or mixed linkage leukemia (MLL)
[33]. The region could be considered as a hotspot of vari-
ous tumors and chromosomal recombination or breakage.
We report the prenatal diagnosis of a de novo interstitial
deletion of 11q (11q22.3→ q23.3) performed by array
CGH in a fetus with polyhydramnios, intrauterine growth
retardation, persistent right umbilical vein and minor car-
diac abnormalities at 28 weeks of gestation. In this study,
we used combinations of classic G-band karotyping, with
array CGH methods to undertake a genome-wide screen-
ing for chromosome aberrations. The array CGH success-
fully detected the 8.9 Mb deletion with its precise location
which could be missed or confused by G-band chromo-
some analysis. It provides valuable information for genetic
counselors to achieve molecular diagnosis of prenatal
anomalies and to make more accurate predictions about
the clinical outcomes. The results indicate that array CGH
is a useful technique for detecting small unbalanced
chromosomal abnormalities and should be an integral part
of prenatal diagnosis for fetal malformations.
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